000 | 02205 a2200565 4500 | ||
---|---|---|---|
005 | 20250517185239.0 | ||
264 | 0 | _c20190814 | |
008 | 201908s 0 0 eng d | ||
022 | _a1523-6838 | ||
024 | 7 |
_a10.1053/j.ajkd.2017.07.018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTrofe-Clark, Jennifer | |
245 | 0 | 0 |
_aResults of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients. _h[electronic resource] |
260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _c03 2018 |
||
300 |
_a315-326 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlack or African American _xgenetics |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xdrug effects |
650 | 0 | 4 |
_aDelayed-Action Preparations _xtherapeutic use |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 | _aGraft Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 |
_aPostoperative Care _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aTacrolimus _xpharmacokinetics |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aBrennan, Daniel C | |
700 | 1 | _aWest-Thielke, Patricia | |
700 | 1 | _aMilone, Michael C | |
700 | 1 | _aLim, Mary Ann | |
700 | 1 | _aNeubauer, Robin | |
700 | 1 | _aNigro, Vincenza | |
700 | 1 | _aBloom, Roy D | |
773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 71 _gno. 3 _gp. 315-326 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.ajkd.2017.07.018 _zAvailable from publisher's website |
999 |
_c27812293 _d27812293 |